Type-1 Diabetes Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 65 pages | ID: TC7F162FBE7AEN
Market Monitor Global

Abstracts

Type-1 diabetes accounts for 5%–10% of all diabetes cases worldwide. Failure to produce insulin is the cause of this type of diabetes.

This report contains market size and forecasts of Type-1 Diabetes Treatment in Global, including the following market information:

Global Type-1 Diabetes Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Type-1 Diabetes Treatment market was valued at 5165.4 million in 2021 and is projected to reach US$ 6938.7 million by 2028, at a CAGR of 4.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Rapid-Acting Insulin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Type-1 Diabetes Treatment include Astellas Pharma, Merck, Eli Lilly, Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim GmbH, Novartis and Pfizer Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Type-1 Diabetes Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Type-1 Diabetes Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Type-1 Diabetes Treatment Market Segment Percentages, by Type, 2021 (%)

• Rapid-Acting Insulin
• Short-Acting Insulin
• Others

Global Type-1 Diabetes Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Type-1 Diabetes Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals & Clinics
• Academic & Research Institutes

Global Type-1 Diabetes Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Type-1 Diabetes Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Type-1 Diabetes Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Type-1 Diabetes Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Astellas Pharma
• Merck
• Eli Lilly
• Novo Nordisk
• Sanofi
• AstraZeneca
• Boehringer Ingelheim GmbH
• Novartis
• Pfizer Inc.
• Abbott Laboratories
• Mannkind Corporation
• Braun Melsungen AG
• Macrogenics, Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Type-1 Diabetes Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Type-1 Diabetes Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TYPE-1 DIABETES TREATMENT OVERALL MARKET SIZE

2.1 Global Type-1 Diabetes Treatment Market Size: 2021 VS 2028
2.2 Global Type-1 Diabetes Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Type-1 Diabetes Treatment Players in Global Market
3.2 Top Global Type-1 Diabetes Treatment Companies Ranked by Revenue
3.3 Global Type-1 Diabetes Treatment Revenue by Companies
3.4 Top 3 and Top 5 Type-1 Diabetes Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Type-1 Diabetes Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Type-1 Diabetes Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Type-1 Diabetes Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Type-1 Diabetes Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Type-1 Diabetes Treatment Market Size Markets, 2021 & 2028
  4.1.2 Rapid-Acting Insulin
  4.1.3 Short-Acting Insulin
  4.1.4 Others
4.2 By Type - Global Type-1 Diabetes Treatment Revenue & Forecasts
  4.2.1 By Type - Global Type-1 Diabetes Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Type-1 Diabetes Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Type-1 Diabetes Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Type-1 Diabetes Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals & Clinics
  5.1.3 Academic & Research Institutes
5.2 By Application - Global Type-1 Diabetes Treatment Revenue & Forecasts
  5.2.1 By Application - Global Type-1 Diabetes Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Type-1 Diabetes Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Type-1 Diabetes Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Type-1 Diabetes Treatment Market Size, 2021 & 2028
6.2 By Region - Global Type-1 Diabetes Treatment Revenue & Forecasts
  6.2.1 By Region - Global Type-1 Diabetes Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Type-1 Diabetes Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Type-1 Diabetes Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Type-1 Diabetes Treatment Revenue, 2017-2028
  6.3.2 US Type-1 Diabetes Treatment Market Size, 2017-2028
  6.3.3 Canada Type-1 Diabetes Treatment Market Size, 2017-2028
  6.3.4 Mexico Type-1 Diabetes Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Type-1 Diabetes Treatment Revenue, 2017-2028
  6.4.2 Germany Type-1 Diabetes Treatment Market Size, 2017-2028
  6.4.3 France Type-1 Diabetes Treatment Market Size, 2017-2028
  6.4.4 U.K. Type-1 Diabetes Treatment Market Size, 2017-2028
  6.4.5 Italy Type-1 Diabetes Treatment Market Size, 2017-2028
  6.4.6 Russia Type-1 Diabetes Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Type-1 Diabetes Treatment Market Size, 2017-2028
  6.4.8 Benelux Type-1 Diabetes Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Type-1 Diabetes Treatment Revenue, 2017-2028
  6.5.2 China Type-1 Diabetes Treatment Market Size, 2017-2028
  6.5.3 Japan Type-1 Diabetes Treatment Market Size, 2017-2028
  6.5.4 South Korea Type-1 Diabetes Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Type-1 Diabetes Treatment Market Size, 2017-2028
  6.5.6 India Type-1 Diabetes Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Type-1 Diabetes Treatment Revenue, 2017-2028
  6.6.2 Brazil Type-1 Diabetes Treatment Market Size, 2017-2028
  6.6.3 Argentina Type-1 Diabetes Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Type-1 Diabetes Treatment Revenue, 2017-2028
  6.7.2 Turkey Type-1 Diabetes Treatment Market Size, 2017-2028
  6.7.3 Israel Type-1 Diabetes Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Type-1 Diabetes Treatment Market Size, 2017-2028
  6.7.5 UAE Type-1 Diabetes Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Astellas Pharma
  7.1.1 Astellas Pharma Corporate Summary
  7.1.2 Astellas Pharma Business Overview
  7.1.3 Astellas Pharma Type-1 Diabetes Treatment Major Product Offerings
  7.1.4 Astellas Pharma Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
  7.1.5 Astellas Pharma Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Type-1 Diabetes Treatment Major Product Offerings
  7.2.4 Merck Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
  7.2.5 Merck Key News
7.3 Eli Lilly
  7.3.1 Eli Lilly Corporate Summary
  7.3.2 Eli Lilly Business Overview
  7.3.3 Eli Lilly Type-1 Diabetes Treatment Major Product Offerings
  7.3.4 Eli Lilly Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
  7.3.5 Eli Lilly Key News
7.4 Novo Nordisk
  7.4.1 Novo Nordisk Corporate Summary
  7.4.2 Novo Nordisk Business Overview
  7.4.3 Novo Nordisk Type-1 Diabetes Treatment Major Product Offerings
  7.4.4 Novo Nordisk Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
  7.4.5 Novo Nordisk Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi Type-1 Diabetes Treatment Major Product Offerings
  7.5.4 Sanofi Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News
7.6 AstraZeneca
  7.6.1 AstraZeneca Corporate Summary
  7.6.2 AstraZeneca Business Overview
  7.6.3 AstraZeneca Type-1 Diabetes Treatment Major Product Offerings
  7.6.4 AstraZeneca Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
  7.6.5 AstraZeneca Key News
7.7 Boehringer Ingelheim GmbH
  7.7.1 Boehringer Ingelheim GmbH Corporate Summary
  7.7.2 Boehringer Ingelheim GmbH Business Overview
  7.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Major Product Offerings
  7.7.4 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
  7.7.5 Boehringer Ingelheim GmbH Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Type-1 Diabetes Treatment Major Product Offerings
  7.8.4 Novartis Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
  7.8.5 Novartis Key News
7.9 Pfizer Inc.
  7.9.1 Pfizer Inc. Corporate Summary
  7.9.2 Pfizer Inc. Business Overview
  7.9.3 Pfizer Inc. Type-1 Diabetes Treatment Major Product Offerings
  7.9.4 Pfizer Inc. Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
  7.9.5 Pfizer Inc. Key News
7.10 Abbott Laboratories
  7.10.1 Abbott Laboratories Corporate Summary
  7.10.2 Abbott Laboratories Business Overview
  7.10.3 Abbott Laboratories Type-1 Diabetes Treatment Major Product Offerings
  7.10.4 Abbott Laboratories Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
  7.10.5 Abbott Laboratories Key News
7.11 Mannkind Corporation
  7.11.1 Mannkind Corporation Corporate Summary
  7.11.2 Mannkind Corporation Business Overview
  7.11.3 Mannkind Corporation Type-1 Diabetes Treatment Major Product Offerings
  7.11.4 Mannkind Corporation Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
  7.11.5 Mannkind Corporation Key News
7.12 Braun Melsungen AG
  7.12.1 Braun Melsungen AG Corporate Summary
  7.12.2 Braun Melsungen AG Business Overview
  7.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Major Product Offerings
  7.12.4 Braun Melsungen AG Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
  7.12.5 Braun Melsungen AG Key News
7.13 Macrogenics, Inc.
  7.13.1 Macrogenics, Inc. Corporate Summary
  7.13.2 Macrogenics, Inc. Business Overview
  7.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Major Product Offerings
  7.13.4 Macrogenics, Inc. Type-1 Diabetes Treatment Revenue in Global Market (2017-2022)
  7.13.5 Macrogenics, Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Type-1 Diabetes Treatment Market Opportunities & Trends in Global Market
Table 2. Type-1 Diabetes Treatment Market Drivers in Global Market
Table 3. Type-1 Diabetes Treatment Market Restraints in Global Market
Table 4. Key Players of Type-1 Diabetes Treatment in Global Market
Table 5. Top Type-1 Diabetes Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Type-1 Diabetes Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Type-1 Diabetes Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Type-1 Diabetes Treatment Product Type
Table 9. List of Global Tier 1 Type-1 Diabetes Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Type-1 Diabetes Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Type-1 Diabetes Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Type-1 Diabetes Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Type-1 Diabetes Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Type-1 Diabetes Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Type-1 Diabetes Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Type-1 Diabetes Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Type-1 Diabetes Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Type-1 Diabetes Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Type-1 Diabetes Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Type-1 Diabetes Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Type-1 Diabetes Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Type-1 Diabetes Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Type-1 Diabetes Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Type-1 Diabetes Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Astellas Pharma Corporate Summary
Table 31. Astellas Pharma Type-1 Diabetes Treatment Product Offerings
Table 32. Astellas Pharma Type-1 Diabetes Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Type-1 Diabetes Treatment Product Offerings
Table 35. Merck Type-1 Diabetes Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Eli Lilly Corporate Summary
Table 37. Eli Lilly Type-1 Diabetes Treatment Product Offerings
Table 38. Eli Lilly Type-1 Diabetes Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Novo Nordisk Corporate Summary
Table 40. Novo Nordisk Type-1 Diabetes Treatment Product Offerings
Table 41. Novo Nordisk Type-1 Diabetes Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Type-1 Diabetes Treatment Product Offerings
Table 44. Sanofi Type-1 Diabetes Treatment Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Type-1 Diabetes Treatment Product Offerings
Table 47. AstraZeneca Type-1 Diabetes Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Boehringer Ingelheim GmbH Corporate Summary
Table 49. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product Offerings
Table 50. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Type-1 Diabetes Treatment Product Offerings
Table 53. Novartis Type-1 Diabetes Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Inc. Corporate Summary
Table 55. Pfizer Inc. Type-1 Diabetes Treatment Product Offerings
Table 56. Pfizer Inc. Type-1 Diabetes Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Abbott Laboratories Corporate Summary
Table 58. Abbott Laboratories Type-1 Diabetes Treatment Product Offerings
Table 59. Abbott Laboratories Type-1 Diabetes Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Mannkind Corporation Corporate Summary
Table 61. Mannkind Corporation Type-1 Diabetes Treatment Product Offerings
Table 62. Mannkind Corporation Type-1 Diabetes Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Braun Melsungen AG Corporate Summary
Table 64. Braun Melsungen AG Type-1 Diabetes Treatment Product Offerings
Table 65. Braun Melsungen AG Type-1 Diabetes Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Macrogenics, Inc. Corporate Summary
Table 67. Macrogenics, Inc. Type-1 Diabetes Treatment Product Offerings
Table 68. Macrogenics, Inc. Type-1 Diabetes Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Type-1 Diabetes Treatment Segment by Type in 2021
Figure 2. Type-1 Diabetes Treatment Segment by Application in 2021
Figure 3. Global Type-1 Diabetes Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Type-1 Diabetes Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Type-1 Diabetes Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Type-1 Diabetes Treatment Revenue in 2021
Figure 8. By Type - Global Type-1 Diabetes Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Type-1 Diabetes Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Type-1 Diabetes Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Type-1 Diabetes Treatment Revenue Market Share, 2017-2028
Figure 12. US Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Type-1 Diabetes Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Type-1 Diabetes Treatment Revenue Market Share, 2017-2028
Figure 24. China Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Type-1 Diabetes Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Type-1 Diabetes Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Type-1 Diabetes Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Astellas Pharma Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eli Lilly Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novo Nordisk Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Inc. Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Abbott Laboratories Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Mannkind Corporation Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Braun Melsungen AG Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Macrogenics, Inc. Type-1 Diabetes Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)